Is extreme blood glucose control increasing or decreasing mortality rate in hospitalized patients?
Read More »Yearly Archives: 2016
HbA1c Testing Becoming a New Norm in Healthcare Setting
HbA1c testing determines diabetes and prediabetes in patients who are not yet diagnosed
Read More »HbA1c Changes Against Microvascular Complications in Type 1 Diabetes
Does HbA1c variability predict retinopathy, nephropathy?
Read More »Exercising and Cardiovascular Risk
Is moderate exercising helping or hurting cardiovascular outcomes?
Read More »How Will CGM’s Success Impact Conventional Glucose Monitors?
Guest Post by David Kliff, Diabetic Investor
The FDA approved Dexcom’s request for a non-adjunctive claim this week. It looks like a bad situation for conventional glucose monitors, and believe it or not is about to get worse. Here’s why.
Question 843
In the fasting state, hyperglycemia is directly related to: 1. Increased hepatic glucose production 2. Defective insulin stimulation of target tissue glucose disposal 3. Decreased adipocyte lipolysis 4. Loss of pancreatic α-cell functionality Did you get it right? Follow the link to find out!
Read More »Cancer Prevention
Do you promote the use of metformin to help prevent cancer as well as to control blood sugars? Follow the link to share your opinion and see what your colleagues think!
Read More »July 21, 2016
The dust has settled from the ADA scientific sessions in New Orleans and we have had time to look at what we learned about SGLT-2 Inhibitors. There were at least 40 posters on how they work and what they can do, but there was not a whole lot about clinical use. …
Read More »Over the last 7 years we have heard all about the benefits of GLP-1 analogs. One of the benefits that is often touted is the increase in first phase insulin release. In simple terms, we define this as “the quick release of insulin at the first bite of food,” but …
Read More »What’s Important to Your Patient?
Male, 26 years of age, type 2 diabetes, obesity, hyperlipidemia, hypertension. Strong family history of type 2 diabetes with complications. Has been a patient since diagnosed 2 years ago. Has met with dietitian. Hasn’t made dietary changes, increased activity, or taken meds prescribed to lower his glucose. A1C 9.2% and rising every 3 months. He would also miss many of his appointments. Stated, “Nothing is going to bother me. Maybe it did my family, but that was a different time and it’s not going to happen to me. I’m going to go on enjoying my life.”
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.